Paper33201699
Triterpenoid-Mediated Inhibition of Virus-Host Interaction: Is Now the Time for Discovering Viral Entry/Release Inhibitors from Nature?
Li H and 4 others. J Med Chem, 2020. Cited by 30 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Triterpenoid-Mediated Inhibition of Virus-Host Interaction: Is Now the Time for Discovering Viral Entry/Release Inhibitors from Nature? Papers, record 33201699. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33201699
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Triterpenoid-Mediated Inhibition of Virus-Host Interaction: Is Now the Time for Discovering Viral Entry/Release Inhibitors from Nature?
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| RNA Viruses | Major topic |
| Triterpenes | Major topic |
| Virus Internalization | Major topic |
| Virus Release | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Humans | |
| Molecular Structure | |
| SARS-CoV-2 | |
| Structure-Activity Relationship | |
| Virus Shedding |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42435079 | Novel mercapto conjugates of oleanolic acid as potential antifungal agents. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42435079 | PubMed |
| 41912781 | Exploring bacterial cytochrome P450s for selective activation of aliphatic C-H bonds in pentacyclic triterpenoids. | Nat Chem | 2026 | https://conductscience.org/library/papers/41912781 | PubMed |
| 41599373 | The Emerging Promise of Pentacyclic Triterpenoid Derivatives as Novel Antiviral Agents Against SARS-CoV-2 Variants. | Molecules | 2026 | https://conductscience.org/library/papers/41599373 | PubMed |
| 41154696 | Natural Compounds with Antiviral Activity Against Clinically Relevant RNA Viruses: Advances of the Last Decade. | Biomolecules | 2025 | https://conductscience.org/library/papers/41154696 | PubMed |
| 39628461 | Design and synthesis of betulinic acid-dithiocarbamate conjugates as potential antifungal agents against Candida albicans. | RSC Adv | 2024 | https://conductscience.org/library/papers/39628461 | PubMed |
| 39065609 | In Silico and In Vitro Studies of Terpenes from the Fabaceae Family Using the Phenotypic Screening Model against the SARS-CoV-2 Virus. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39065609 | PubMed |
| 38276760 | Triterpenoidal Saponins from the Leaves of Aster koraiensis Offer Inhibitory Activities against SARS-CoV-2. | Plants (Basel) | 2024 | https://conductscience.org/library/papers/38276760 | PubMed |
| 38067489 | Friedelin: Structure, Biosynthesis, Extraction, and Its Potential Health Impact. | Molecules | 2023 | https://conductscience.org/library/papers/38067489 | PubMed |
| 37367540 | Transcriptome and Metabolome Integration Reveals the Impact of Fungal Elicitors on Triterpene Accumulation in Sanghuangporus sanghuang. | J Fungi (Basel) | 2023 | https://conductscience.org/library/papers/37367540 | PubMed |
| 36903578 | Triterpene Derivatives as Potential Inhibitors of the RBD Spike Protein from SARS-CoV-2: An In Silico Approach. | Molecules | 2023 | https://conductscience.org/library/papers/36903578 | PubMed |
| 36851106 | Phytoestrogen β-Sitosterol Exhibits Potent In Vitro Antiviral Activity against Influenza A Viruses. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/36851106 | PubMed |
| 36674943 | Anti-HIV Potential of Beesioside I Derivatives as Maturation Inhibitors: Synthesis, 3D-QSAR, Molecular Docking and Molecular Dynamics Simulations. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36674943 | PubMed |
| 36297280 | Recent Advances in Antiviral Activities of Triterpenoids. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/36297280 | PubMed |
| 35646545 | A clickable photoaffinity probe of betulinic acid identifies tropomyosin as a target. | Acta Pharm Sin B | 2022 | https://conductscience.org/library/papers/35646545 | PubMed |
| 35283698 | Anti-viral triterpenes: a review. | Phytochem Rev | 2022 | https://conductscience.org/library/papers/35283698 | PubMed |
| 35116174 | Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection. | J Adv Res | 2022 | https://conductscience.org/library/papers/35116174 | PubMed |
| 34953146 | Antiviral plant-derived natural products to combat RNA viruses: Targets throughout the viral life cycle. | Lett Appl Microbiol | 2022 | https://conductscience.org/library/papers/34953146 | PubMed |
| 33946174 | Fluorescence Correlation Spectroscopy Analysis of Effect of Molecular Crowding on Self-Assembly of β-Annulus Peptide into Artificial Viral Capsid. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33946174 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33201699
GET https://conductscience.org/api/papers/v1/33201699/authors